76 related articles for article (PubMed ID: 2239408)
1. [Left supraclavicular adenopathy as a symptom of prostatic adenocarcinoma].
Ziad F; Serrano Heranz R; Lacasa Marzo J; Aznar Muñoz R
Actas Urol Esp; 1990; 14(3):243. PubMed ID: 2239408
[No Abstract] [Full Text] [Related]
2. [Left supraclavicular adenopathy. Metastasis of carcinoma of the prostate].
Avila Padilla J; Capell González M; Centelles Ruiz M; Ardiaca Bosch MC; Badía Torroella F; Abós Fanlo P
Arch Esp Urol; 1993 May; 46(4):289-93. PubMed ID: 8338368
[TBL] [Abstract][Full Text] [Related]
3. [Left supraclavicular adenopathy with a neuroendocrine pattern of unknown cause: prostatic carcinoma metastasis].
Fernández Borrell A; Peinado Ibarra F; Gómez Sancha F; Teba del Pino F; Minguez Martínez R; Morato Robert P; Arellano Gañan R; Romero Tejada JC; Pereira Sanz I
Actas Urol Esp; 1999; 23(7):603-8. PubMed ID: 10488615
[TBL] [Abstract][Full Text] [Related]
4. [Left supraclavicular adenopathy as a presenting feature of occult prostatic adenocarcinoma].
González Serrano M; del Villar Sordo V; Puras Tellaeche A; Sanz Millán M
Med Clin (Barc); 1989 Mar; 92(11):439. PubMed ID: 2725103
[No Abstract] [Full Text] [Related]
5. [Occult adenocarcinoma of the prostate and supraclavicular adenopathies].
Solá C; Paredes A; Orube A; Piera JM
Med Clin (Barc); 1989 Sep; 93(8):317-8. PubMed ID: 2607839
[No Abstract] [Full Text] [Related]
6. [Cancer of the prostate with predominant lymphatic manifestation. Apropos of 2 cases].
Herer B; Waligora J; Delfraissy JF; Dormont J
J Urol (Paris); 1987; 93(8):475-7. PubMed ID: 3440840
[TBL] [Abstract][Full Text] [Related]
7. [Biological behavior of prostatic carcinoma. II. Clinico-surgical studies on lymphogenic metastasizing of prostatic carcinoma].
Schubert J; Gorski J
Urologe A; 1983 Sep; 22 Suppl():356-9. PubMed ID: 6314623
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer metastasis to supraclavicular lymph node.
Hobdy EM; Shafi NQ; Kummar S
Clin Adv Hematol Oncol; 2004 Apr; 2(4):223-4; discussion 224. PubMed ID: 16163185
[No Abstract] [Full Text] [Related]
9. [Lymphatic metastasis in prostatic carcinoma. Diagnostic value of staging and transcutaneous needle biopsy].
Rothenberger K; Hofstetter A; Pfeifer KJ; Voeth C; Pensel J
Fortschr Med; 1980 Sep; 98(34):1279-82. PubMed ID: 7461533
[TBL] [Abstract][Full Text] [Related]
10. Prostatic carcinoma presenting as left supraclavicular lymphadenopathy.
Chaudhuri KR; Ghosh SK
Br J Clin Pract; 1990 Dec; 44(12):722-3. PubMed ID: 2102211
[No Abstract] [Full Text] [Related]
11. Supraclavicular lymphadenopathy and carcinoma of the prostate: aspiration cytology in the diagnosis of both.
Fletcher DR; Orell SR
Med J Aust; 1974 Dec; 2(24):866-9. PubMed ID: 4453257
[No Abstract] [Full Text] [Related]
12. Difficult diagnostic and therapeutic cases: CASE 3. presentation of prostate cancer with cervical adenopathy.
Gaur S; Aish LS; Oo TH
J Clin Oncol; 2004 Mar; 22(5):957-8. PubMed ID: 14990654
[No Abstract] [Full Text] [Related]
13. Carcinoma of prostatic origin. Metastatic to cervical lymph nodes.
Nussbaum M
N Y State J Med; 1973 Aug; 73(16):2050-4. PubMed ID: 4516609
[No Abstract] [Full Text] [Related]
14. [Study of surgically removed pelvic lymph nodes in the staging of prostatic carcinoma].
Hoekstra JW; Schröder FH
Ned Tijdschr Geneeskd; 1982 Dec; 126(50):2291-4. PubMed ID: 7155208
[No Abstract] [Full Text] [Related]
15. Two unusual cases of metastasis of prostatic cancer: metastases to the spermatic cord and the epididymis.
Wilenius R; Seppänen J
Ann Chir Gynaecol Fenn; 1969; 58(2):172-5. PubMed ID: 5370000
[No Abstract] [Full Text] [Related]
16. A case of prostate cancer with a large abdominal mass effectively treated with a high dose of diethylstilbestrol-diphosphate.
Wakisaka M; Takagishi H
Hinyokika Kiyo; 1993 Sep; 39(9):849-51. PubMed ID: 8213382
[TBL] [Abstract][Full Text] [Related]
17. [Prostatic cancer: pathological analysis of autopsied cases].
Takahashi Y; Mayuzumi T; Satoh J
Hinyokika Kiyo; 1986 Jun; 32(6):835-9. PubMed ID: 3766343
[TBL] [Abstract][Full Text] [Related]
18. Nodal involvement as prognostic indicator in prostatic carcinoma.
Prout GR; Griffin PP; Daly JJ; Shipley WU
Urology; 1981 Mar; 17(Suppl 3):72-9. PubMed ID: 7210370
[No Abstract] [Full Text] [Related]
19. Staging of M0 prostatic adenocarcinoma: how aggressive should one be?
Olsson CA
Prog Clin Biol Res; 1984; 153():455-67. PubMed ID: 6473408
[No Abstract] [Full Text] [Related]
20. Adenocarcinoma of the prostate metastatic to the testis via lymphatic invasion: a case report.
Brandon ML; Odom SR; Barone JE; Waxberg JA
Conn Med; 2005 Feb; 69(2):69-70. PubMed ID: 15779601
[No Abstract] [Full Text] [Related]
[Next] [New Search]
